Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
2 Subscribers
Podcast hosts
- MoiraGunn
@MoiraGunn
© Tech Nation Media
BioTech Nation ... with Dr. Moira Gunn
Read more
2 Subscribers
Reviews
No reviews yet
Podcast information
- Amount of episodes
- 23
- Subscribers
- 2
- Verified
- Yes
- Website
- Explicit content
- No
- Episode type
- episodic
- Podcast link
- https://podvine.com/link/..
- Last upload date
- March 22, 2023
- Last fetch date
- March 23, 2023 12:23 AM
- Upload range
- WEEKLY
- Author
- Moira Gunn
- Copyright
- Tech Nation Media
susbcribers
- Hand Foot Skin Reaction - A Painful Chemotherapy Side Effect - Could There Be a Treatment?? Dr. Mike McCullar, CEO of OnQuality PharmaceuticalsA side effect of chemotherapy, where hands and feet may be raw, painful, and immobilized. With no current treatment, a new candidate has just finished Phase II clinical trials. We’ll hear from Dr. Michael McCullar, the CEO of OnQuality Pharmaceuticals.0 comments0
- Can the Mapping of Human Biology Lead to Better Drugs? Dr. Chris Gibson, the co-founder and CEO of Recursion PharmaceuticalsDr. Chris Gibson, the co-founder and CEO of Recursion Pharmaceuticals in Salt Lake City. We talk about their efforts to map ALL of human biology, and how this mapping will lead to better drugs.0 comments0
- BioTech Nation ... with Dr. Moira Gunn Mar 9 · 30m Has Medtech Excluded Persons of Color & Women?? Dr. Patrice Matchaba President, Novartis US FoundationDr. Patrice Matchaba, the President of the Novartis US Foundation, shows us how medical technology can create systemic racism, both in the medical field and in human clinical trials.0 comments0
- Safe NON-OPIOID Pain Relief - Is It Possible? Dr. Hernan Bazan, Co-Fdr & CEO, South Rampart PharmaThe next generation of pain relief – non-opioid pain relief - with the goal of being equally powerful pain relief without addiction. Dr Hernan Bazan is the Co-Founder & CEO of South Rampart Pharma in New Orleans.0 comments0
- 23-07 Joe Hernandez, Founder & CEO, Blue Water VaccinesEven Saturday Night Live couldn’t resist the story of a “genetics engineering company” trying to de-extinct the dodo bird. Blue Water Vaccines, founder and CEO Joe Hernandez tells us about his early quest to develop a universal flu vaccine, bringing him face-to-face – so to speak – with the Oxford Dodo. And of course, he funds decoding its DNA.0 comments0
- 23-06 Dr. Randy Schatzman, President & CEO, Bolt BiotherapeuticsBolt Biotherapeutics’ Dr. Randy Schatzman talks about the role of myeloid cells in teaching our immune systems to recognize tumors in our own bodies and then eliminate them. Nearly two dozen forms of HER2-related cancers are being studied. (16 mins)0 comments0
- BioTech Nation ... with Dr. Moira Gunn Jan 25 · 25m 23-04 Sir Rory Collins, Oxford Professor and Principal Investigator, UK BiobankSir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.0 comments0
- 22-52 Edward Humes, Pulitzer Prize Winner, "The Forever Witness"In a long-form feature from Tech Nation, it’s Pulitzer Prize-winning author, Edward Humes, with “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an object lesson in the Three Ages of DNA from a forensic investigation standpoint, and while it reads like a fast-paced Cold Case on steroids – it provides details no fiction writer would dare to make up, including the unexpected involvement of the famous true crimes writer, Ann Rule, and a person whose DNA skills are familiar to fans of the PBS documentary series, “Finding Your Roots with Henry Louis Gates, Jr.”0 comments0
- BioTech Nation ... with Dr. Moira Gunn Dec 14 · 14m 22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR TherapeuticsCancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO, talks about just two of the candidates in its pipeline: One is for Non-small cell lung cancer and another for ER+ breast cancer, with these and other clinical trials enrolling now.0 comments0
- 22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTxLike the idea of replacing some of your DNA with DNA that works better? And what if you want that new DNA to stop? Dr. Alexandria Forbes, the President & CEO of MeiraGTx, tells us about their work in retinitis pigmentosa and Parkinson’s – two of many clinical trials enrolling right now.0 comments0
- 22-47 Dr. James Mackay, President & CEO, Aristea TherapeuticsToo much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's called PPP, or Palmoplantar Pustulosis. Dr. James Mackay is the President & CEO of Aristea Therapeutics.0 comments0
- 22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis BioAlzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they have in common? Dr. Maria Maccecchini, the Founder, President & CEO of Annovis Bio, says, "Sticky proteins".0 comments0
- 22-45 Dr. Amit Kumar, President & CEO, Anixa BiosciencesAnixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has the potential to treat other breast cancers as well as ovarian cancer. Dr. Amit Kumar is the President & CEO. More information is available at anixa.com.1 comments1
- BioTech Nation ... with Dr. Moira Gunn Jun 14 · 36m Dr. George Yancopoulos, CEO, RegeneronDr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid treatment, directly infusing antibodies. This, of course, requires innovative science … but how do get students to become scientists? Dr. Yancopoulos has an answer.0 comments0
- Dr. Daniel Bloomfield, Chief Medical Officer, Anthos TherapeuticsBlood clots of any sort are dangerous. So dangerous in fact, that 1 in 4 people die from blood clots - independent of medical condition, medicines they take, or medical procedures they undergo. Dr. Daniel Bloomfield, the Chief Medical Officer of Anthos Therapeutics, describes their approach to preventing bleeding while avoiding blood clotting.0 comments0
- Mark Litton, President & CEO, Athira PharmaAlzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma.0 comments0
✋ Yay! You have heard it all
Podcast hosts
- MoiraGunn
@MoiraGunn
© Tech Nation Media
